Barbara G. Kravitz

Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy

Steven E. Kahn, Steven M. Haffner, Mark Heise et al. · New England Journal of Medicine · 2006 · 2.9K citations

Medicine, Endocrinology, Pharmacotherapy +13

Rosiglitazone-Associated Fractures in Type 2 Diabetes

Steven E. Kahn, Bernard Zinman, John M. Lachin et al. · Diabetes Care · 2008 · 537 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +15

Effects of Rosiglitazone, Glyburide, and Metformin on β-Cell Function and Insulin Sensitivity in ADOPT

Steven E. Kahn, John M. Lachin, Bernard Zinman et al. · Diabetes · 2011 · 248 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Obesity Is a Major Determinant of the Association of C-Reactive Protein Levels and the Metabolic Syndrome in Type 2 Diabetes

Steven E. Kahn, Bernard Zinman, Steven M. Haffner et al. · Diabetes · 2006 · 189 citations · Full text

Veterinary Medicine, Chronic Disease Prevention, Diabetology +16

Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes

Bernard Zinman, Steven M. Haffner, William H. Herman et al. · The Journal of Clinical Endocrinology & Metabolism · 2009 · 179 citations · Full text

Medicine, Endocrinology, Pharmacology +15